Furthermore, when analyzing for potential mutations responsible for tumor immune escape, only in one of the patients with a non-paired acquired resistant tumor lesion, stop-gaining mutations were found in the B2M and PTEN genes. This evidence concerns the gene PTEN and neoplasm.